Ara-290
An EPO-derived peptide studied for neuropathic pain, small fiber neuropathy, and tissue protection.
Neuropeptide FF (NPFF) is an RFamide neuropeptide that functions as an anti-opioid or opioid-modulating peptide. Researchers study its critical role in endogenous pain control and its implications for opioid tolerance.
In the literature, Neuropeptide FF appears most often in work focused on pain research, neuroprotection and stress. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.
Because it is catalogued here under powder peptides, Neuropeptide FF also shows up in discussions of nerve pain. Coverage across those topics varies widely in quality and depth, and much of it is early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.
Tap a topic to see which peptides are most studied for it.
An EPO-derived peptide studied for neuropathic pain, small fiber neuropathy, and tissue protection.
A neuropeptide preparation studied for neuroprotection, cognitive function, and recovery after brain injury.
A potent opioid-receptor peptide used strictly in analgesic and receptor research.
Research use only. This page summarizes areas of published study and is not medical advice. No dosing, protocol, or usage guidance is provided.